Deanne Miller
Direttore operativo presso IMMUTEP LIMITED
Patrimonio netto: 977 806 $ in data 31/05/2024
Profilo
Deanne Miller is currently the Co-Managing Director at Immutep GmbH and the COO, Secretary & General Counsel at Immutep Ltd.
She is also a Member of The Law Society of New South Wales.
Previously, she worked as an Associate Director at Westpac Banking Corp., a Manager-Legal & Compliance at Macquarie Group Ltd., and a Legal Counsel at RBC Investor Services Trust (Australia).
Ms. Miller completed her undergraduate and graduate degrees at The University of Sydney.
Partecipazioni note in società pubbliche
Società | Data | Numero di azioni | Valorizzazione | Data di valutazione |
---|---|---|---|---|
IMMUTEP LTD
0.27% | 22/08/2023 | 3 267 305 ( 0.27% ) | 977 806 $ | 31/05/2024 |
Posizioni attive di Deanne Miller
Società | Posizione | Inizio |
---|---|---|
IMMUTEP LIMITED | Direttore operativo | 01/11/2016 |
The Law Society of New South Wales | Corporate Officer/Principal | - |
Immutep GmbH
Immutep GmbH BiotechnologyHealth Technology Part of Immutep Ltd., Immutep GmbH develops novel immunotherapy treatments for cancer and autoimmune disease. The company is based in Leipzig, Germany. The CEOs of the German company are - Kaufmann, Marc Voigt, Deanne Miller. | Amministratore Delegato | - |
Precedenti posizioni note di Deanne Miller
Società | Posizione | Fine |
---|---|---|
MACQUARIE GROUP LIMITED | Responsabile della Conformità | - |
RBC Investor Services Trust (Australia) | Consigliere Generale | - |
WESTPAC BANKING CORPORATION | Corporate Officer/Principal | - |
Formazione di Deanne Miller
The University of Sydney | Graduate Degree |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
Società quotate in Borsa | 3 |
---|---|
WESTPAC BANKING CORPORATION | Finance |
IMMUTEP LIMITED | Health Technology |
MACQUARIE GROUP LIMITED | Finance |
Aziende private | 3 |
---|---|
The Law Society of New South Wales | |
RBC Investor Services Trust (Australia) | Finance |
Immutep GmbH
Immutep GmbH BiotechnologyHealth Technology Part of Immutep Ltd., Immutep GmbH develops novel immunotherapy treatments for cancer and autoimmune disease. The company is based in Leipzig, Germany. The CEOs of the German company are - Kaufmann, Marc Voigt, Deanne Miller. | Health Technology |
- Borsa valori
- Insiders
- Deanne Miller